Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study

Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study

Abstract Background Treating pneumonia in old patients remains challenging for clinicians. Moreover, bacterial antimicrobial resistance is a major public health threat. Objective The PROPAGE study evaluated the interest of a strategy using serial measurements of procalcitonin (PCT) to reduce the dur...

Full description

Bibliographic Details
Main Authors: Gaëtan Gavazzi, Sabine Drevet, Matthieu Debray, Jean Luc Bosson, Fatah Tidadini, Marc Paccalin, Benoit de Wazieres, Thomas Celarier, Marc Bonnefoy, Virginie Vitrat
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Geriatrics
Subjects:
Aged
Antibiotic duration
Bacterial infection biomarkers
Pneumonia
Procalcitonin
Online Access:https://doi.org/10.1186/s12877-022-03658-4

Internet

https://doi.org/10.1186/s12877-022-03658-4

Similar Items